BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23821771)

  • 1. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
    Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
    Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d.
    Markovic D; Lehnert H; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2008 Nov; 22(11):2505-19. PubMed ID: 18772229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of signaling molecules mediating corticotropin-releasing hormone-R1alpha-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation.
    Punn A; Levine MA; Grammatopoulos DK
    Mol Endocrinol; 2006 Dec; 20(12):3179-95. PubMed ID: 16959871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta.
    Markovic D; Vatish M; Gu M; Slater D; Newton R; Lehnert H; Grammatopoulos DK
    Endocrinology; 2007 Jul; 148(7):3205-13. PubMed ID: 17431005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of corticotropin-releasing hormone family peptides in androgen receptor and vitamin D receptor expression and translocation in human breast cancer MCF-7 cells.
    Jin L; Chen C; Guo R; Wan R; Li S
    Eur J Pharmacol; 2012 Jun; 684(1-3):27-35. PubMed ID: 22494987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRH-R splicing in estrogen-sensitive breast cancer.
    Grammatopoulos DK
    Cell Cycle; 2014; 13(5):687-8. PubMed ID: 24526122
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.
    Papadopoulou N; Chen J; Randeva HS; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2004 Mar; 18(3):624-39. PubMed ID: 14657255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of structural determinants of type 1 corticotropin releasing hormone (CRH) receptor signalling properties.
    Markovic D; Grammatopoulos DK
    Methods Mol Biol; 2010; 634():285-307. PubMed ID: 20676992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes.
    Grammatopoulos DK; Dai Y; Randeva HS; Levine MA; Karteris E; Easton AJ; Hillhouse EW
    Mol Endocrinol; 1999 Dec; 13(12):2189-202. PubMed ID: 10598591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors.
    Cantarella G; Lempereur L; Lombardo G; Chiarenza A; Pafumi C; Zappalà G; Bernardini R
    Br J Pharmacol; 2001 Oct; 134(4):837-44. PubMed ID: 11606324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.
    Graziani G; Tentori L; Muzi A; Vergati M; Tringali G; Pozzoli G; Navarra P
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):44-9. PubMed ID: 17097220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells.
    Papadopoulou NG; Oleson L; Kempuraj D; Donelan J; Cetrulo CL; Theoharides TC
    J Mol Endocrinol; 2005 Dec; 35(3):R1-8. PubMed ID: 16326828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
    Sengupta S; Schiff R; Katzenellenbogen BS
    Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing hormone stimulates SGK-1 kinase expression in cultured hippocampal neurons via CRH-R1.
    Sheng H; Sun T; Cong B; He P; Zhang Y; Yan J; Lu C; Ni X
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E938-46. PubMed ID: 18713960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel corticotropin-releasing hormone type 1beta-like receptor variant lacking Exon 13 in human pregnant myometrium regulated by estradiol-17beta and progesterone.
    Karteris E; Markovic D; Chen J; Hillhouse EW; Grammatopoulos DK
    Endocrinology; 2010 Oct; 151(10):4959-68. PubMed ID: 20702571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.